Document Detail

The effects of demineralized bone matrix proteins and osteogenic protein-1 on bone cells isolated in culture.
MedLine Citation:
PMID:  16817587     Owner:  NLM     Status:  MEDLINE    
With the growing number of bone-related traumas and the limitations of traditional bone repair, alternative methods of bone management must be investigated. Demineralized bone matrix protein (DBX) has been used to reconstruct bone. DBX, a type of demineralized bone matrix, is a combination of several different proteins including osteogenic protein-1 (OP-1). Osteogenic protein-1 or Bone Morphogenic Protein-7 (BMP-7) was the first BMP approved for clinical use in the United States. Previous studies have shown that proliferation of osteoblasts (bone forming cells) was stimulated by OP-1. However, the effects of DBM and OP-1 at the cellular level have not been clearly defined. MG-63 osteosarcoma cells were utilized as a model and subsequently plated onto 24 well tissue culture plates at a density of 1x 10(5) ml/well. Cells were exposed to different concentrations of DBX demineralized bone matrix and OP-1 for periods of 24, 48, and 72 hours and compared with untreated controls. After each incubation period, cell morphology, cell damage, cell number, and protein concentrations were determined. Results indicate a significant increase in cell number at 72 hours in cells treated with 30% (5.66 x 10(5)) and 100% (6.3 x 10(5)) DBX treated groups when compared with the control (1.4 x 10(5)). OP-1 results do not indicate a significant increase in cell number at the 24 and 48 hour treatment phases when compared with the control (p > 0.05), however, results do show a statistically significant difference (approximately twofold, p < 0.05) between the control cells (1.9 x 10(4)) and those cells treated with low (3.9 x 10(4)) and high (4.1 x 10(4)) concentrations of OP-1 at the 72 hour time phase. The increases in cell number indicate that both DBX and OP-1 are effective in stimulating cell growth. When comparing the results of the DBX treatments with those of the OP-1 treatments, the cells treated with DBX showed a more substantial increase in bone cell proliferation after treatment than those cells treated with OP-1. This does suggest that DBX provides the most effective treatment for bone cell proliferation. Closer evaluation of the morphology especially the changes occurring at the nuclear level need to be addressed in future studies.
Tabitha Hardy; Ham Benghuzzi; George Russell; Joseph Cameron; Michelle Tucci
Related Documents :
2318587 - Retinal pigment epithelium wound closure in vitro. pharmacologic inhibition.
1373847 - Analysis of toxic and mutagenic activities of antiherpesvirus nucleosides against hela ...
18410387 - In vitro evaluation of casein phosphopeptide-amorphous calcium phosphate as a potential...
20347917 - Bitter melon (momordica charantia) triterpenoid extract reduces preadipocyte viability,...
8275487 - Negative regulation of histone h1 kinase expression by mimosine, a plant amino acid.
3378487 - Respiratory cytopathology in chlorine gas toxicity: a study in 28 subjects.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Biomedical sciences instrumentation     Volume:  42     ISSN:  0067-8856     ISO Abbreviation:  Biomed Sci Instrum     Publication Date:  2006  
Date Detail:
Created Date:  2006-07-04     Completed Date:  2006-07-27     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0140524     Medline TA:  Biomed Sci Instrum     Country:  United States    
Other Details:
Languages:  eng     Pagination:  66-71     Citation Subset:  IM    
Jackson State University, Jackson, MS 39216, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bone Demineralization Technique*
Bone Morphogenetic Protein 7
Bone Morphogenetic Proteins / administration & dosage*,  isolation & purification
Cell Differentiation / drug effects
Cell Line
Cell Proliferation / drug effects
Cell Size / drug effects
Cell Survival / drug effects
Dose-Response Relationship, Drug
Osteoblasts / cytology*,  drug effects,  physiology*
Reg. No./Substance:
0/BMP7 protein, human; 0/Bone Morphogenetic Protein 7; 0/Bone Morphogenetic Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of growth factors on cell migration and alkaline phosphatase release.
Next Document:  Pathophysiological responses of MRC-5 cells exposed to various doses of x-ray radiation.